Other Viruses Citation List:
December 22 - January 6, 2011
Herpes simplex virus
1. Development of Anti-Viral Agents Using Molecular Modeling and Virtual Screening Techniques. Kirchmair, J., S. Distinto, K.R. Liedl, P. Markt, J.M. Rollinger, D. Schuster, G.M. Spitzer, and G. Wolber. Infectious disorders drug targets, 2010. [Epub ahead of print]; PMID[21189123].
[Pubmed]. OV_1222-010611.
Hepatitis B virus
2. Synthesis and in Vitro Anti-Hepatitis B Virus Activity of Six-Membered Azanucleoside Analogues. Wang, D., Y.H. Li, Y.P. Wang, R.M. Gao, L.H. Zhang, and X.S. Ye. Bioorganic & Medicinal Chemistry, 2011. 19(1): p. 41-51; PMID[21183354].
[Pubmed]. OV_1222-010611.
3. Synthesis and Anti-Hepatitis B Virus Activity of a Novel Class of Thiazolylbenzimidazole Derivatives. Luo, Y., J.P. Yao, L. Yang, C.L. Feng, W. Tang, G.F. Wang, J.P. Zuo, and W. Lu. Archiv Der Pharmazie, 2010. [Epub ahead of print]; PMID[21181737].
[Pubmed]. OV_1222-010611.
Hepatitis C virus
4. Specific Interaction of Hepatitis C Virus Glycoproteins with Mannan Binding Lectin Inhibits Virus Entry. Brown, K.S., M.J. Keogh, A.M. Owsianka, R. Adair, A.H. Patel, J.N. Arnold, J.K. Ball, R.B. Sim, A.W. Tarr, and T.P. Hickling. Protein & cell, 2010. 1(7): p. 664-74; PMID[21203938].
[Pubmed]. OV_1222-010611.
5. An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of Hcv Replication. Parker, M.A., E. Satkiewicz, T. Hermann, and B.M. Bergdahl. Molecules (Basel, Switzerland), 2010. 16(1): p. 281-90; PMID[21193848].
[Pubmed]. OV_1222-010611.
6. Selection of Peptides Binding to Hcv E2 and Inhibiting Viral Infectivity. Hong, H.W., S.W. Lee, and H. Myung. Journal of Microbiology and Biotechnology, 2010. 20(12): p. 1769-71; PMID[21193836].
[Pubmed]. OV_1222-010611.
7. New Direct-Acting Antivirals in the Development for Hepatitis C Virus Infection. Pockros, P.J. Therapeutic advances in gastroenterology, 2010. 3(3): p. 191-202; PMID[21180601].
[Pubmed]. OV_1222-010611.
8. A Novel Class of Geldanamycin Derivatives as Hcv Replication Inhibitors Targeting on Hsp90: Synthesis, Structure-Activity Relationships and Anti-Hcv Activity in Gs4.3 Replicon Cells. Shan, G.Z., Z.G. Peng, Y.H. Li, D. Li, Y.P. Li, S. Meng, L.Y. Gao, J.D. Jiang, and Z.R. Li. The Journal of antibiotics, 2010. [Epub ahead of print]; PMID[21179047].
[Pubmed]. OV_1222-010611.
9. Inhibitors of Endoplasmic Reticulum Alpha-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release. Qu, X., X. Pan, J. Weidner, W. Yu, D. Alonzi, X. Xu, T. Butters, T. Block, J.T. Guo, and J. Chang. Antimicrobial Agents and Chemotherapy, 2010. [Epub ahead of print]; PMID[21173177].
[Pubmed]. OV_1222-010611.